Search Results

There are 12519 results for: content related to: Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

  1. You have free access to this content
    MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 582–593, GuoQi Zhu, YuYing Huang, Ying Chen, YingHan Zhuang and Thomas Behnisch

    Version of Record online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07815.x

  2. Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

    Journal of Neuroscience Research

    Volume 88, Issue 7, 15 May 2010, Pages: 1522–1536, Hironori Yokoyama, Hayato Kuroiwa, Tatsuya Tsukada, Hiroto Uchida, Hiroyuki Kato and Tsutomu Araki

    Version of Record online : 8 DEC 2009, DOI: 10.1002/jnr.22310

  3. You have free access to this content
    The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

    Journal of Neurochemistry

    Volume 76, Issue 5, March 2001, Pages: 1265–1274, Serge Przedborski, Vernice Jackson-Lewis, Ali B. Naini, Michael Jakowec, Giselle Petzinger, Reginald Miller and Muhammad Akram

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00183.x

  4. You have full text access to this OnlineOpen article
    Near-infrared light is neuroprotective in a monkey model of Parkinson disease

    Annals of Neurology

    Volume 79, Issue 1, January 2016, Pages: 59–75, Fannie Darlot, Cécile Moro, Nabil El Massri, Claude Chabrol, Daniel M. Johnstone, Florian Reinhart, Diane Agay, Napoleon Torres, Dhaïf Bekha, Vincent Auboiroux, Thomas Costecalde, Cassandra L. Peoples, Helena D. T. Anastascio, Victoria E. Shaw, Jonathan Stone, John Mitrofanis and Alim-Louis Benabid

    Version of Record online : 12 DEC 2015, DOI: 10.1002/ana.24542

  5. You have free access to this content
    Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Journal of Neurochemistry

    Volume 122, Issue 5, September 2012, Pages: 1032–1046, Sophie Schumm, Claude Sebban, Charles Cohen-Salmon, Jacques Callebert, Jean-Marie Launay, Jean-Louis Golmard, Lydie Boussicault, Isabelle Petropoulos, Audrey Hild, Estelle Rousselet, Annick Prigent, Bertrand Friguet, Jean Mariani and Etienne C. Hirsch

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1471-4159.2012.07837.x

  6. You have full text access to this OnlineOpen article
    Role of the MPTP in conditioning the heart – translatability and mechanism

    British Journal of Pharmacology

    Volume 172, Issue 8, April 2015, Pages: 2074–2084, S-B Ong, R K Dongworth, H A Cabrera-Fuentes and D J Hausenloy

    Version of Record online : 8 JAN 2015, DOI: 10.1111/bph.13013

  7. Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression

    Journal of Comparative Neurology

    Volume 504, Issue 6, 20 October 2007, Pages: 690–701, Gilmor I. Keshet, Ravi J. Tolwani, Angelica Trejo, Peggy Kraft, Regis Doyonnas, Carol Clayberger, James M. Weimann and Helen M. Blau

    Version of Record online : 22 AUG 2007, DOI: 10.1002/cne.21483

  8. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia

    Journal of Neuroscience Research

    Volume 77, Issue 3, 1 August 2004, Pages: 378–390, Beth E. Fisher, Giselle M. Petzinger, Kerry Nixon, Elizabeth Hogg, Samuel Bremmer, Charles K. Meshul and Michael W. Jakowec

    Version of Record online : 20 MAY 2004, DOI: 10.1002/jnr.20162

  9. Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse

    Journal of Neuroscience Research

    Volume 91, Issue 11, November 2013, Pages: 1492–1507, N. Kintz, G.M. Petzinger, G. Akopian, S. Ptasnik, C. Williams, M.W. Jakowec and J.P. Walsh

    Version of Record online : 6 AUG 2013, DOI: 10.1002/jnr.23260

  10. You have free access to this content
    MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway

    British Journal of Pharmacology

    Volume 172, Issue 9, May 2015, Pages: 2354–2368, Guoqi Zhu, Junyao Li, Ling He, Xuncui Wang and Xiaoqi Hong

    Version of Record online : 26 MAR 2015, DOI: 10.1111/bph.13061

  11. Neuroprotection in Parkinson models varies with toxin administration protocol

    European Journal of Neuroscience

    Volume 24, Issue 11, December 2006, Pages: 3174–3182, David W. Anderson, Kristin A. Bradbury and Jay S. Schneider

    Version of Record online : 11 DEC 2006, DOI: 10.1111/j.1460-9568.2006.05192.x

  12. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys

    Journal of Neuroscience Research

    Volume 87, Issue 2, 1 February 2009, Pages: 586–597, Pablo Garrido-Gil, Silvia Belzunegui, Waldy San Sebastián, Amaya Izal-Azcárate, Berta López, Irene Marcilla and Maria Rosario Luquin

    Version of Record online : 16 SEP 2008, DOI: 10.1002/jnr.21845

  13. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress

    European Journal of Neuroscience

    Volume 28, Issue 1, July 2008, Pages: 41–50, Patricia Rojas, Norma Serrano-García, José J. Mares-Sámano, Omar Noel Medina-Campos, José Pedraza-Chaverri and Sven Ove Ögren

    Version of Record online : 4 JUL 2008, DOI: 10.1111/j.1460-9568.2008.06314.x

  14. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  15. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

    Journal of Neuroscience Research

    Volume 93, Issue 12, December 2015, Pages: 1849–1864, Lacey Pflibsen, Katherine A. Stang, Michelle D. Sconce, Vanessa B. Wilson, Rebecca L. Hood, Charles K. Meshul and Suzanne H. Mitchell

    Version of Record online : 31 AUG 2015, DOI: 10.1002/jnr.23638

  16. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice

    Journal of Pineal Research

    Volume 58, Issue 3, April 2015, Pages: 262–274, Amit Naskar, Visakh Prabhakar, Raghavendra Singh, Debashis Dutta and Kochupurackal P. Mohanakumar

    Version of Record online : 23 FEB 2015, DOI: 10.1111/jpi.12212

  17. You have free access to this content
    In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment

    Journal of Neurochemistry

    Volume 127, Issue 3, November 2013, Pages: 365–377, Puneet Bagga, Anup N. Chugani, Komanduri S. Varadarajan and Anant B. Patel

    Version of Record online : 16 SEP 2013, DOI: 10.1111/jnc.12407

  18. You have free access to this content
    Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions

    Journal of Neurochemistry

    Volume 109, Issue 5, June 2009, Pages: 1469–1482, Claire Gibrat, Martine Saint-Pierre, Mélanie Bousquet, Daniel Lévesque, Claude Rouillard and Francesca Cicchetti

    Version of Record online : 28 MAR 2009, DOI: 10.1111/j.1471-4159.2009.06072.x

  19. You have free access to this content
    VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease

    Journal of Neurochemistry

    Volume 105, Issue 1, April 2008, Pages: 78–90, Ming-Kai Chen, Hiroto Kuwabara, Yun Zhou, Robert J. Adams, James R. Brašić, Jennifer L. McGlothan, Tatyana Verina, Neal C. Burton, Mohab Alexander, Anil Kumar, Dean F. Wong and Tomás R. Guilarte

    Version of Record online : 6 NOV 2007, DOI: 10.1111/j.1471-4159.2007.05108.x

  20. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

    European Journal of Neuroscience

    Volume 29, Issue 11, June 2009, Pages: 2177–2186, David A. Price, Alex A. Martinez, Alexandre Seillier, Wouter Koek, Yolanda Acosta, Elizabeth Fernandez, Randy Strong, Beat Lutz, Giovanni Marsicano, James L. Roberts and Andrea Giuffrida

    Version of Record online : 21 MAY 2009, DOI: 10.1111/j.1460-9568.2009.06764.x